Your browser doesn't support javascript.
loading
Management strategies and prognosis of patients ineligible for transcatheter mitral valve replacement.
Hasan, Syeda A; Morsi, Moustafa; Frakes, Belinda S; Bryson, Marien E; Schmidt, Christian W; Seshiah, Puvi; Choo, Joseph; Smith, J Michael; Answini, Geoffrey A; Stewart-Dehner, Terri L; Yasar, Senan J; Jollis, James G; Berlacher, Mark D; Ratajczak, Teresa M; Chung, Eugene S; Kereiakes, Dean J; Garcia, Santiago.
Affiliation
  • Hasan SA; The Christ Hospital Heart and Vascular Institute and Lindner Center for Research and Education, Cincinnati, OH, United States of America.
  • Morsi M; The Christ Hospital Heart and Vascular Institute and Lindner Center for Research and Education, Cincinnati, OH, United States of America.
  • Frakes BS; Lindner Center for Research and Education, Cincinnati, OH, United States of America.
  • Bryson ME; Lindner Center for Research and Education, Cincinnati, OH, United States of America.
  • Schmidt CW; The Christ Hospital Heart and Vascular Institute and Lindner Center for Research and Education, Cincinnati, OH, United States of America.
  • Seshiah P; The Christ Hospital Heart and Vascular Institute and Lindner Center for Research and Education, Cincinnati, OH, United States of America.
  • Choo J; The Christ Hospital Heart and Vascular Institute and Lindner Center for Research and Education, Cincinnati, OH, United States of America.
  • Smith JM; The Christ Hospital Heart and Vascular Institute and Lindner Center for Research and Education, Cincinnati, OH, United States of America.
  • Answini GA; The Christ Hospital Heart and Vascular Institute and Lindner Center for Research and Education, Cincinnati, OH, United States of America.
  • Stewart-Dehner TL; The Christ Hospital Heart and Vascular Institute and Lindner Center for Research and Education, Cincinnati, OH, United States of America.
  • Yasar SJ; The Christ Hospital Heart and Vascular Institute and Lindner Center for Research and Education, Cincinnati, OH, United States of America.
  • Jollis JG; The Christ Hospital Heart and Vascular Institute and Lindner Center for Research and Education, Cincinnati, OH, United States of America.
  • Berlacher MD; The Christ Hospital Heart and Vascular Institute and Lindner Center for Research and Education, Cincinnati, OH, United States of America.
  • Ratajczak TM; The Christ Hospital Heart and Vascular Institute and Lindner Center for Research and Education, Cincinnati, OH, United States of America.
  • Chung ES; The Christ Hospital Heart and Vascular Institute and Lindner Center for Research and Education, Cincinnati, OH, United States of America.
  • Kereiakes DJ; The Christ Hospital Heart and Vascular Institute and Lindner Center for Research and Education, Cincinnati, OH, United States of America.
  • Garcia S; The Christ Hospital Heart and Vascular Institute and Lindner Center for Research and Education, Cincinnati, OH, United States of America. Electronic address: santiagogarcia@me.com.
Cardiovasc Revasc Med ; 64: 1-4, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38355340
ABSTRACT

BACKGROUND:

Transcatheter mitral valve replacement (TMVR) faces anatomical challenges, currently limiting widespread adoption.

OBJECTIVES:

To describe the natural history and prognosis of patients ineligible for various TMVR devices.

METHODS:

During a 4-year period (2019-2023) 3 TMVR devices (SAPIEN M3, Intrepid and Alta Valve) became available at a single institution (The Christ Hospital, Cincinnati, OH) in the setting of pivotal clinical trials or early feasibility study. Consenting patients who were deemed ineligible ≥1 of these trials were prospectively studied to capture anatomical reasons for ineligibility, cross-over to alternative mitral valve therapies (surgery or high-risk mitral transcatheter edge to edge repair [M-TEER]), and clinical events.

RESULTS:

A total of 61 patients (out of 71 consenting patients or 85.9 %) were deemed ineligible for TMVR during the study period. The mean age was 79.2 ± 8.8 years, 65.6 % were female, with elevated surgical risk (median STS 4.3, IQR 2.7-7.3). The 2 most common anatomical reasons for ineligibility were increased risk of left ventricular outflow tract obstruction (LVOTO) (n = 24, 39.3 %) and annular size (n = 29, 47.5 %). During follow-up (median 277 [162-555] days) there were 7 deaths (11.5 %) and 12 (19.7 %) hospitalizations for heart failure. Management strategies included high-risk M-TEER in 11 patients (1 death [9.0 %], 0 HF hospitalizations [0 %]), surgery in 9 patients (0 deaths, 1 HF hospitalizations [11.1 %]), and medical management in 41 patients (6 deaths [14.6 %], 11 HF hospitalizations [26.8 %]) (p = 0.715 for mortality and p = 0.093 for HF hospitalizations). Residual MR ≥ moderate was 0 %, 50 %, and 100 % for surgery, M-TEER and medical treatment, respectively (p < 0.001).

CONCLUSIONS:

One third of patients deemed ineligible for TMVR are candidates for high-risk M-TEER or surgery with acceptable morbidity and mortality. Our results have practical implications for patient management.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart Valve Prosthesis / Cardiac Catheterization / Patient Selection / Heart Valve Prosthesis Implantation / Eligibility Determination / Mitral Valve / Mitral Valve Insufficiency Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Cardiovasc Revasc Med / Cardiovasc. revasc. med / Cardiovascular revascularization medicine Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart Valve Prosthesis / Cardiac Catheterization / Patient Selection / Heart Valve Prosthesis Implantation / Eligibility Determination / Mitral Valve / Mitral Valve Insufficiency Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Cardiovasc Revasc Med / Cardiovasc. revasc. med / Cardiovascular revascularization medicine Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos